NASDAQ · Medical - Devices

Spectral AI, Inc. (MDAI) Stock

$1.67 +1.79% NASDAQ: MDAI Healthcare

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds.

Valuation

MetricValue
Price$1.67
Market Cap$53.12M
P/E Ratio-3.10
P/B Ratio-5.91
P/S Ratio3.13
EPS (TTM)$-0.29
52-Week High$2.97
52-Week Low$1.18
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE179.24%
ROA-80.58%
ROCE280.19%
Gross Margin-40.00%
Operating Margin-45.00%
Net Margin-85.58%
Debt/Equity-1.13
Current Ratio0.90

Annual Financials (USD)

Metric20212022202320242025
Revenue$15.0M$25.0M$18.0M$30.0M$20.0M
Operating Profit$-4.0M$-3.0M$-13.0M$-7.0M$-9.0M
Net Profit$-4.0M$-3.0M$-21.0M$-15.0M$-8.0M
EPS$-0.33$-0.16$-1.48$-0.85$-0.29
Op Margin-27.4%-10.4%-71.9%-22.3%-43.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$19.0M$19.0M$11.0M$12.0M$21.0M
Total Liabilities$5.0M$7.0M$12.0M$19.0M$27.0M
Cash$16.0M$14.0M$5.0M$5.0M$15.0M
Borrowings$1.0M$1.0M$1.0M$5.0M$10.0M

Latest News

Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication GlobeNewswire · Jul 8, 2026 DeepView® System Highlighted at the 2026 British Burn Association Annual Conference GlobeNewswire · Jun 25, 2026 Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month GlobeNewswire · Jun 12, 2026 Spectral AI to Participate in 2026 British Burn Association Annual Conference GlobeNewswire · Jun 11, 2026 Spectral AI Announces Voting Results of Annual Meeting of Stockholders GlobeNewswire · Jun 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-1.0M$-13.0M$-9.0M$-10.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$1.0M$0$0
Net Cash Flow$11.0M$-2.0M$-9.0M$0$10.0M
Free Cash Flow$-3.0M$-1.0M$-13.0M$-9.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.07
EV / EBITDA-3.97
FCF Yield-18.82%
Quick Ratio0.86
Interest Coverage-4.50
Return 1Y-39.68%
Return 3Y-84.08%
Return 5Y-82.46%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
COEPCoeptis Therapeutics Holdings, Inc. $10.99 -8.57% -4.45 $38.62M 0.00%
CTSO $0.35 -4.32% -3.62 $22.25M 0.00%
ECORelectroCore, Inc. $6.02 -2.75% -3.42 $49.94M 0.00%
EQ $2.57 +3.21% -5.28 $91.29M 0.00%
ICCM $2.88 +3.23% -1.00 $6.49M 0.00%

About Spectral AI, Inc.

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.

Spectral AI, Inc. is led by CEO Vincent Stanley Capone, employs 78 people, headquartered in US, publicly traded since 2021.

Spectral AI, Inc. (MDAI) stock trades at $1.67 with a market capitalization of $53.12M. The stock is valued at a price-to-earnings (P/E) ratio of -3.10, price-to-book of -5.91, price-to-sales of 3.13. Over the past 52 weeks the stock has ranged between $1.18 and $2.97, and currently trades 43.8% below its 52-week high.

On profitability, Spectral AI, Inc. generates a return on equity (ROE) of 179.24% — well above the market average, a sign of a high-quality business, return on capital employed of 280.19%, an operating margin of -45.00%, a net profit margin of -85.58%.

Official website: www.spectral-ai.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides